| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.24 | 0.05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |